Email Updates

You are here

Home

15 JUNE 2018 VOLUME 19 ISSUE 24

Media Coverage

  • HIV—No time for complacency

    There is no room for complacency when so much more remains to be done for HIV prevention and treatment. The task of breaking down barriers and building bridges needs greater commitment and impetus. Now is not the time to take the foot off the pedal of the global AIDS response if the United Nations Sustainable Development Goal target of a 90% reduction in HIV incidence by 2030 is to be met.

    June 15, 2018
    Combination Prevention, General
    Science

  • Building TRUST in an LGBTQ-hostile country

    A clinic in Abuja, run by the Institute for Human Virology, Nigeria, bills itself as "MSM friendly" and dodges the legal hurdles to test and treat this community for HIV and other sexually transmitted infections.

    June 15, 2018
    Treatment
    Science

  • Far from over

    A unique package of graphics looks at HIV/AIDS around the world using five different metrics. By these gauges, Nigeria, Russia, and Florida stand out from their neighbors and, in some cases, the entire world.

    June 15, 2018
    General
    Science

  • Babies who dodge HIV may not be unscathed

    A research project in Benin City run by the Institute for Human Virology, Nigeria, is attempting to assess whether exposure to the virus—or to antiretroviral drugs taken by the mother and baby that thwart transmission—may cause harm.

    June 15, 2018
    Treatment
    Science

  • Viral suppression reduces cancer risk but does not affect common cancers

    People with HIV whose viral load has been fully suppressed for at least two years have a significantly lower risk of developing any form of cancer than other people with HIV, but still retain a higher risk of developing cancer than HIV-negative people of a similar age, a study of US military veterans published in Annals of Internal Medicine shows.

    June 15, 2018
    Treatment
    aidsmap

  • Strategies for a Cure

    Three researchers talk with PA editor Jeff Berry about ongoing HIV cure research within the ACTG, treatment interruptions, and when we might see a cure.

    June 15, 2018
    Cure
    Positively Aware

  • Stigma may keep women from using HIV-prevention drugs

    Fear of others thinking they’re promiscuous, or that they’re already infected with HIV, is a barrier to many women who might benefit from pills that help prevent the infection, a US study suggests.

    June 14, 2018
    PrEP
    Reuters

  • GSK's two-drug HIV treatment meets main goal in late stage studies

    The combination of dolutegravir and lamivudine was shown to be as effective as a dolutegravir-based combination of three drugs, GSK’s majority-owned ViiV Healthcare said on Thursday. It said its push for two-drug regimens addressed long-term toxicity concerns of people living with HIV by reducing the number of medicines.

    June 14, 2018
    Treatment
    Reuters

  • ‘We’re in a mess.’ Why Florida is struggling with an unusually severe HIV/AIDS problem

    "Miami is the epicenter of the epicenter of HIV/AIDS in the United States," says Mario Stevenson, a virologist with a thick Scottish brogue who heads the infectious disease department at the University of Miami (UM) Miller School of Medicine, which shares a campus with Jackson Memorial. "There's no abatement in our upward slope."

    June 13, 2018
    Combination Prevention, PrEP, Treatment
    Science

  • Why so many new HIV infections in US, despite PrEP availability?

    At this stage in the scale-up of US PrEP programs, it is important to systematically and comprehensively analyze and integrate knowledge about the successes of and the barriers to PrEP implementation. Our review provides a comprehensive analysis and informs the direction of PrEP implementation across a variety of settings.

    June 13, 2018
    PrEP
    Medical Research

  • The critical importance of retention in HIV prevention

    In The Lancet HIV, Brandon Marshall and colleagues report the results of a modelling study that compared effectiveness of exclusive long-acting injectable PrEP implementation with that of exclusive oral PrEP implementation in a virtual population of men who have sex with men in Atlanta, GA.

    June 13, 2018
    PrEP
    Lancet HIV

  • The Trump administration wants to make HIV a pre-existing condition again

    In what may be the most drastic move to date, the Trump administration has decided it will not defend the law against a suit brought by Republican-controlled states that will end one of Obamacare’s most popular provisions: the ban on using pre-existing conditions as an excuse to deny coverage.

    June 13, 2018
    Treatment
    LGBTQ Nation

  • App improving care for people with HIV, study finds

    A smartphone app designed to improve care for people living with HIV has increased users’ consistency in doctor visits and improved their health outcomes, a new study has found.

    June 13, 2018
    Treatment
    Augusta Free Press

  • Nigeria has more HIV-infected babies than anywhere in the world. It’s a distinction no country wants

    Mother-to-child transmission is only one part of Nigeria’s HIV epidemic. But that route of transmission epitomizes the country’s faltering response to the crisis, highlighting major gaps in HIV testing that allow infections to go untreated and the virus to spread.

    June 12, 2018
    Treatment
    Science

  • Trump’s gag rule and alarm over HIV pill are partners in sex panic

    Abortion rights and PrEP prophylactics both allow for sex free of fear, which is exactly what opponents of sexual liberation don’t want.

    June 11, 2018
    PrEP
    The Village Voice

  • Russia’s HIV/AIDS epidemic is getting worse, not better

    Almost anywhere in the world, an HIV-infected woman who has an uninfected partner and wants to have a baby would be first in line to receive ARVs. The challenges Katia faced in getting treatment amid Russia’s epidemic highlight the country’s faltering response, which critics have blasted as misguided, lackadaisical, and downright dismissive.

    June 11, 2018
    Treatment
    Science

  • As an HIV prevention drug surged in Australia, condom use fell

    Infection rates declined despite an rise in unprotected sex, suggesting widespread use of the drug may mitigate the effects of riskier behavior.

    June 11, 2018
    Male and Female Condoms, PrEP
    New York Times

  • In the face of a misguided response to HIV/AIDS in Russia, these bright stars are taking charge

    Why did it take until 2015 for a prominent Russian to finally reveal that he was living with HIV? “We are still Soviet,” Lobkov says. “And we are still trying to keep our problems inside us.”

    June 11, 2018
    General
    Science

  • Health ministers adopt African Medicines Agency treaty

    The decision to establish an African Medicines Agency is hailed as a turning point in efforts to advance regulatory oversight but also draws calls for caution.

    June 9, 2018
    General
    Lancet

  • Swedish Court decriminalizes unprotected sex for HIV-infected people on therapy

    In a precedent-setting ruling, the Supreme Court of Sweden ruled that "thorough treatment" minimized the risk of infection, thus making a dent in the divulgence requirement for the HIV-positive before having unprotected sex.

    June 8, 2018
    Treatment
    Sputnik News

  • Health and Vaccine Research Set to Lose Out From New EU Research Budget

    The European Commission may be planning to hike spending for its flagship research programme, but health and scientific research, particularly into new vaccines, was not one of the winners from the proposal announced on Thursday.

    June 7, 2018
    HIV Vaccine, General, PrEP
    Euractiv

  • Four ongoing tests offer hope against HIV infection

    His hope is to see an HIV vaccine developed during his lifetime that could prevent those who are not infected from getting the disease, and also to address the burden of taking pills every day — for those already living with the virus.

    June 6, 2018
    General
    The East African

Published Research

Announcements